Highlights Pacific Edge Limited

Equities

PEB

NZPEBE0002S1

End-of-day quote New Zealand S.E. Other stock markets 06:00:00 2024-05-23 pm EDT			5-day change	1st Jan Change
0.1 ^NZD	0.00%		+2.04%	-14.53%

May. 21	Pacific Edge FY2024 Operating Revenue Jumps 22% to NZ$23.9 Million, Total Revenue Rises 12% to NZ$29.3 Million	MT
May. 21	Pacific Edge Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pacific Edge FY2024 Operating Revenue Jumps 22% to NZ$23.9 Million, Total Revenue Rises 12% to NZ$29.3 Million	May. 21	MT
Pacific Edge Limited Reports Earnings Results for the Full Year Ended March 31, 2024	May. 21	CI
Pacific Edge Reports Steady Growth in Bladder Cancer Test Volumes in Fiscal Q4	Apr. 08	MT
Pacific Edge Limited Reports Earnings Results for the Half Year Ended September 30, 2023	Nov. 23	CI
Pacific Edge Plans Coordinated Response to US FDA Proposal to Regulate Lab-Developed Tests	23-10-02	MT
Pacific Edge Limited Announces Medicare Coverage of Cxbladder Tests in the US Market is Expected to Cease from 17 July 2023	23-06-06	CI
Pacific Edge Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-25	CI
Pacific Edge Completes Software Integration of Diagnostic Test with Kaiser Permanente	23-03-31	MT
Pacific Edge Limited Provides Update on Kaiser EMR Integration	23-03-30	CI
Pacific Edge Announces the Acceptance for Publication of New Clinical Evidence That Shows Significant Improvements in the Performance of its Genomic Diagnostic Cxbladder Tests	22-12-12	CI
Pacific Edge Limited Reports Earnings Results for the Half Year Ended September 30, 2022	22-11-24	CI
Pacific Edge's April-September Net Loss Widens on Higher Operating Costs	22-11-24	MT
Pacific Edge Limited Completes a Commercial Agreement with Te Whatu Ora Southern	22-09-21	CI
Pacific Edge Signs Deal for Use of Bladder Cancer Diagnostic Test in New Zealand; Shares Rise 3%	22-07-20	MT
Southern District Health Region Adopts Pacific Edge's Cxbladder Tests	22-07-20	CI
Pacific Edge Announces Kaiser Permanente Agrees to Cxbladder Emr Integration	22-06-01	CI
Pacific Edge Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-05-25	CI
Pacific Edge to Start Clinical Trial of Bladder Cancer Diagnostic Test	22-05-10	MT
Pacific Edge Limited Announces It Is Advancing Its Clinical Evidence Generation Program with Lobster	22-05-09	CI
Pacific Edge Limited Announces Agreement with Northern Health in Australia	21-12-08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Pacific Edge Limited

Equities

PEB

NZPEBE0002S1

Highlights

Filters